Should I go up a step to break the stall?

Answer

This app does not answer that. What the trials show is a real but limited dose response, with the biggest gap at the bottom of the schedule rather than the top.

In more detail

SURMOUNT-1 reported mean reductions of roughly 16%, 21% and 22.5% at 5 mg, 10 mg and 15 mg by week 72 — a clear dose response, and a shrinking one. Going up is a clinical decision with a tolerability cost attached to it, and it is your prescriber's to make. What the app can do is list the readings you entered over those weeks, in date order, so you and your prescriber can look at them together.

Source

SURMOUNT-1 (Jastreboff 2022, PMID 35658024).

Educational use only, never medical advice. No doses.